FDA grants states more time to sign compounding MOU before enforcing distribution limits
Regulatory NewsJoanne S. Eglovitch
ComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy